quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:34:29·51d
INSIDERFiling
Silgan Holdings Inc. logo

EVP, Corp. Dev. & Admin. Lewis Robert B covered exercise/tax liability with 7,806 shares, decreasing direct ownership by 5% to 134,572 units (SEC Form 4)

SLGN· Silgan Holdings Inc.
Industrials
Original source

Companies

  • SLGN
    Silgan Holdings Inc.
    Industrials

Recent analyst ratings

  • Apr 1UpdateDeutsche Bank$52.00
  • Jan 15UpdateRBC Capital Mkts$43.00
  • Nov 24UpdateUBS$42.00
  • Oct 17UpdateRaymond James$53.00
  • Aug 28UpdateBofA Securities$57.00
  • Jul 9UpdateBofA Securities$59.00

Related

  • SEC7d
    SEC Form DEF 14A filed by Silgan Holdings Inc.
  • PR13d
    Silgan to Release First Quarter 2026 Earnings Results on April 29, 2026
  • ANALYST22d
    Deutsche Bank initiated coverage on Silgan Holdings with a new price target
  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by Silgan Holdings Inc.
  • INSIDER51d
    SVP, Strategy and IR Hutter Alexander G covered exercise/tax liability with 1,286 shares and was granted 19,500 shares, increasing direct ownership by 42% to 61,725 units (SEC Form 4)
  • INSIDER51d
    EVP, Gen. Counsel & Sec. Hogan Frank W Iii covered exercise/tax liability with 8,736 shares and was granted 15,500 shares, increasing direct ownership by 2% to 319,720 units (SEC Form 4)
  • INSIDER51d
    SVP & Chief Accounting Officer Ulmer Kimberly Irene covered exercise/tax liability with 8,631 shares and was granted 12,700 shares, increasing direct ownership by 4% to 118,590 units (SEC Form 4)
  • INSIDER51d
    EVP & Chief Financial Officer Fabry Shawn C covered exercise/tax liability with 2,064 shares and was granted 20,500 shares, increasing direct ownership by 24% to 95,949 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022